Active Stocks
Mon Mar 18 2024 15:55:53
  1. Tata Steel share price
  2. 149.60 5.69%
  1. Tata Motors share price
  2. 972.20 2.75%
  1. ITC share price
  2. 417.40 -0.51%
  1. State Bank Of India share price
  2. 730.70 -0.18%
  1. ICICI Bank share price
  2. 1,082.00 0.32%
Business News/ Companies / GVK Biosciences to set up new research lab in Vizag
BackBack

GVK Biosciences to set up new research lab in Vizag

The new facility will house chemistry and biology laboratories of 200,000 litres capacity

The proposed plant, to come up a on 10 acre land parcel in Ramky Pharma City in Vizag, is expected to be completed in two years time, said Manni Kantipudi, chief executive officer of GVK Biosciences said. Premium
The proposed plant, to come up a on 10 acre land parcel in Ramky Pharma City in Vizag, is expected to be completed in two years time, said Manni Kantipudi, chief executive officer of GVK Biosciences said.

GVK Biosciences Pvt. Ltd, a Hyderabad-based contract research organization (CRO), on Friday said it plans to invest around 100 crore to set up a new facility in the coastal city of Vizag as part of its expansion plans.

The new facility will house chemistry and biology laboratories of 200,000 litres capacity, the company said.

The proposed plant, to come up a on 10 acre land parcel in Ramky Pharma City in Vizag, is expected to be completed in two years time, said Manni Kantipudi, chief executive officer of GVK Biosciences said.

Earlier this year, GVK Biosciences set up formulation plant in Bangalore.

Kantipudi, without disclosing revenue and profit figures, said GVK Biosciences registered topline growth of 40% in the quarter ended 31 December, with a much better percentage of profits.

GVK earns about 50% of its revenue through drug discovery research services, while the remaining comes from contract manufacturing, informatics and clinical research.

Kantipudi said the clinical research business that contributes 11% revenues was hit by government’s new guidelines on clinical trials and legal issues.

“There is lack of regulatory clarity on clinical trials, and government is not giving approvals for fresh clinical trial programmes," Kantipudi said.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 21 Mar 2014, 07:15 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie